Answer
No. It is a bispecific antibody immunotherapy that redirects T cells towards CD20-expressing lymphoma cells.
Sources for this answer
- Tepkinly 48 mg solution for injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.